Skip to main content
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 4, Number 8, December 2004

Review article

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
pp. 621-635(15)
Authors: Rao, Ravi D.; Buckner, Jan C.; Sarkaria, Jann N.

Favourites:
ADD

Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects
pp. 637-651(15)
Authors: Nikitakis, N. G.; Siavash, H.; Sauk, J. J.

Favourites:
ADD

Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
pp. 653-671(19)
Authors: Luu, Hue H.; Zhang, Ruiwen; Haydon, Rex C.; Rayburn, Elizabeth; Kang, Quan; Si, Weike; Park, Jong K.; Wang, Hui; Peng, Ying; Jiang, Wei; He, Tong- Chuan

Favourites:
ADD
Favourites:
ADD

Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
pp. 689-702(14)
Authors: Michl, P.; Gress, T. M.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more